First, the dynamic expression patterns of USP38 across various stages of CKD and its time-dependent effects on AF susceptibility remain incompletely characterized, necessitating longitudinal studies to delineate critical therapeutic windows. The gene discussed is USP38; the disease is atrial fibrillation.